HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Cancer Genomics

Changes in the DNA of cells cause cancer. Cancer genomics identifies genetic changes, defines molecular subtypes, and develops precision medicine techniques for cancer treatment using technologies such as sequencing. Genome sequencing is providing physicians greater information about the causes of cancer and modifying how some cancers are treated. Genomic assays allow for the identification of somatic and germline abnormalities in individual tumor samples, are becoming more widely employed in clinical diagnostics as a means of determining therapeutic alternatives. Genomic-based tests are increasingly being used as part of evidence-based diagnosis to help patients with cancer get better care.

•              Precision Oncology
•              Genomic Heterogeneity and Tumors
•              Liquid Biopsy
•              Immunogenomics

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp